CSR Wire

Medtronic Study of Investigational Nellcor™ Pulse Oximetry Technology Demonstrates Positive Results Across a Full Range of Skin Tones

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
Morningstar

Medtronic Receives FDA Clearance for Nellcor(TM) Pulse Oximetry System With Nell-EQ(TM) Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
CSR Wire

Medtronic Receives FDA Clearance for Nellcor™ Pulse Oximetry System With Nell-EQ™ Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse ...

June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...